At the 72nd Scientific Sessions of the American Diabetes Association, Tandem announced that it will begin accepting orders for the t:slim™ Insulin Delivery System, the first insulin pump approved by the FDA with a touch screen, on Monday, June 11, 2012 starting at 6:00am. The product will begin shipping in August 2012.
Full press release is below.
PHILADELPHIA, June 8, 2012 —Tandem Diabetes Care™, Inc. (“Tandem”) announced today at the 72nd Scientific Sessions of the American Diabetes Association that it will begin accepting orders for the t:slim™ Insulin Delivery System, the first insulin pump approved by the FDA with a touch screen, on Monday, June 11, 2012. The product will begin shipping in August 2012.
“Since the t:slim Insulin Delivery System received FDA clearance, we have been conducting user evaluations to further demonstrate its performance and reliability, as well as the readiness of our team,” said Kim Blickenstaff, CEO, Tandem Diabetes Care. “t:slim is proving to be to be easy to teach, easy to learn, and easy to use, and our 24/7 Customer Technical Support Team is also finding it easy to support.”
People interested in the t:slim Insulin Delivery System can begin the order process starting at 6:00am PDT on June 11, 2012. More information is available online at www.TandemDiabetes.com, or by calling 1-877-801-6901. Tandem’s Customer Sales Support Team is available Monday through Friday from 6:00am to 6:00pm PDT to accept orders.
The t:slim Insulin Pump has the footprint of a credit card and the look of a smart phone. Currently the smallest FDA-cleared insulin delivery system, t:slim is up to 25% slimmer than other 300 unit pumps. Unlike other insulin pumps that have complex menus and require excessive button pressing, t:slim’s vivid, color touch screen is the window to an easy-to-use interface that places everything at the touch of a finger.
